| __timestamp | Travere Therapeutics, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47795223 | 45967000 |
| Thursday, January 1, 2015 | 50426000 | 114737000 |
| Friday, January 1, 2016 | 70853000 | 183204000 |
| Sunday, January 1, 2017 | 78168000 | 231644000 |
| Monday, January 1, 2018 | 123757000 | 293998000 |
| Tuesday, January 1, 2019 | 140963000 | 357355000 |
| Wednesday, January 1, 2020 | 131773000 | 412084000 |
| Friday, January 1, 2021 | 210328000 | 497153000 |
| Saturday, January 1, 2022 | 235780000 | 705789000 |
| Sunday, January 1, 2023 | 244990000 | 648449000 |
Unleashing insights
In the competitive landscape of biopharmaceuticals, innovation is the lifeblood of progress. Over the past decade, Ultragenyx Pharmaceutical Inc. and Travere Therapeutics, Inc. have demonstrated a steadfast commitment to research and development (R&D), a critical driver of their growth and success.
From 2014 to 2023, Ultragenyx has consistently outpaced Travere in R&D spending, with an average annual investment nearly 2.6 times higher. Notably, Ultragenyx's R&D expenses surged by over 1,300% from 2014 to 2022, peaking in 2022. Meanwhile, Travere's R&D spending grew by approximately 413% during the same period, reflecting its strategic focus on innovation.
This data underscores the pivotal role of R&D in advancing medical breakthroughs and enhancing patient outcomes. As these companies continue to invest in cutting-edge research, they are poised to shape the future of healthcare.
Research and Development: Comparing Key Metrics for GSK plc and Ultragenyx Pharmaceutical Inc.
Comparing Innovation Spending: United Therapeutics Corporation and Ultragenyx Pharmaceutical Inc.
R&D Spending Showdown: Genmab A/S vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.
Research and Development Investment: Ultragenyx Pharmaceutical Inc. vs CRISPR Therapeutics AG
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.
R&D Insights: How Travere Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds